| Primary |
| Crohn's Disease |
28.9% |
| Diarrhoea |
14.8% |
| Hypercholesterolaemia |
12.5% |
| Hypertension |
10.2% |
| Rheumatoid Arthritis |
6.3% |
| Osteoporosis |
3.9% |
| Hyperlipidaemia |
3.1% |
| Blood Cholesterol |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Chelation Therapy |
2.3% |
| Cardiac Operation |
1.6% |
| Constipation |
1.6% |
| Embolism |
1.6% |
| Fatigue |
1.6% |
| Gastrointestinal Disorder |
1.6% |
| Overdose |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Atrial Fibrillation |
0.8% |
| Benign Prostatic Hyperplasia |
0.8% |
| Blood Cholesterol Abnormal |
0.8% |
|
| Vomiting |
8.9% |
| Drug Ineffective |
6.7% |
| Medication Error |
6.7% |
| Weight Decreased |
6.7% |
| Cerebrovascular Accident |
4.4% |
| Constipation |
4.4% |
| Diarrhoea |
4.4% |
| Dysgeusia |
4.4% |
| Liver Disorder |
4.4% |
| Migraine |
4.4% |
| Myalgia |
4.4% |
| Neutropenia |
4.4% |
| Organising Pneumonia |
4.4% |
| Pneumonia |
4.4% |
| Premature Baby |
4.4% |
| Pulmonary Oedema |
4.4% |
| Rash |
4.4% |
| Renal Failure Acute |
4.4% |
| Rhabdomyolysis |
4.4% |
| Thrombocytopenia |
4.4% |
|
| Secondary |
| Crohn's Disease |
18.5% |
| Rheumatoid Arthritis |
18.1% |
| Hypercholesterolaemia |
9.6% |
| Drug Use For Unknown Indication |
9.4% |
| Hypertension |
6.6% |
| Product Used For Unknown Indication |
6.4% |
| Drug Detoxification |
5.0% |
| Vitamin Supplementation |
3.4% |
| Osteoporosis |
3.2% |
| Diarrhoea |
3.0% |
| Prophylaxis |
2.4% |
| Constipation |
2.0% |
| Pharyngitis |
2.0% |
| Gastric Ulcer |
1.8% |
| Conjunctivitis |
1.6% |
| Short-bowel Syndrome |
1.6% |
| Sleep Disorder |
1.6% |
| Chelation Therapy |
1.2% |
| Gastrointestinal Pain |
1.2% |
| Hypovitaminosis |
1.2% |
|
| Renal Failure Acute |
15.7% |
| White Blood Cell Count Decreased |
8.6% |
| Bursitis |
7.1% |
| Osteoporosis |
5.7% |
| Stevens-johnson Syndrome |
5.7% |
| Vomiting |
5.7% |
| Gamma-glutamyltransferase Increased |
4.3% |
| Hepatic Function Abnormal |
4.3% |
| Leukoencephalopathy |
4.3% |
| Pruritus |
4.3% |
| Pyrexia |
4.3% |
| Rash |
4.3% |
| Renal Failure |
4.3% |
| Renal Tubular Disorder |
4.3% |
| Drug Hypersensitivity |
2.9% |
| Drug Ineffective |
2.9% |
| Electrolyte Imbalance |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Myalgia |
2.9% |
| Nasopharyngitis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Crohn's Disease |
20.7% |
| Drug Use For Unknown Indication |
12.1% |
| Diarrhoea |
5.4% |
| Hypertension |
4.7% |
| Pain |
3.9% |
| Depression |
3.1% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Nausea |
2.3% |
| Vitamin Supplementation |
2.3% |
| Osteoporosis |
2.2% |
| Rheumatoid Arthritis |
2.0% |
| Prophylaxis |
1.9% |
| Premedication |
1.7% |
| Atrial Fibrillation |
1.5% |
| Irritable Bowel Syndrome |
1.5% |
| Abdominal Pain |
1.3% |
| Diabetes Mellitus |
1.3% |
| Hepatic Neoplasm Malignant |
1.2% |
| Blood Cholesterol Increased |
1.2% |
|
| Weight Decreased |
18.2% |
| Vomiting |
16.8% |
| Urinary Tract Infection |
6.3% |
| Pulmonary Embolism |
4.9% |
| Diarrhoea |
4.5% |
| Vision Blurred |
4.5% |
| Pyrexia |
4.2% |
| Injection Site Pain |
3.8% |
| Nausea |
3.8% |
| Wrist Fracture |
3.8% |
| Fatigue |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Dyspnoea |
3.1% |
| Pneumonia |
3.1% |
| Headache |
2.8% |
| Myocardial Infarction |
2.8% |
| Renal Failure Acute |
2.8% |
| Crohn's Disease |
2.4% |
| Pain In Extremity |
2.4% |
| Rash |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.1% |
| Gastrointestinal Pain |
23.8% |
| Product Used For Unknown Indication |
19.0% |
| Clostridium Difficile Colitis |
9.5% |
| Rheumatoid Arthritis |
4.8% |
| Therapeutic Procedure |
4.8% |
|
| Osteoporosis |
50.0% |
| Drug Interaction |
16.7% |
| International Normalised Ratio Increased |
16.7% |
| Red Blood Cell Sedimentation Rate Increased |
16.7% |
|
